1. Design, Characterization, and Biopharmaceutical Behavior of Nanoparticles Loaded with an HIV-1 Fusion Inhibitor Peptide. Ariza-Saenz, M., M. Espina, A. Calpena, M.J. Gomara, I. Perez-Pomeda, I. Haro, and M.L. Garcia. Molecular Pharmaceutics, 2018. 15(11): p. 5005-5018. PMID[30226777].
[PubMed]. HIV_12_2018.
2. Procyanidin Trimer C1 Reactivates Latent HIV as a Triple Combination Therapy with Kansui and JQ1. Cary, D.C. and B.M. Peterlin. Plos One, 2018. 13(11): e0208055. PMID[30475902]. PMCID[PMC6258234].
[PubMed]. HIV_12_2018.
3. Synthesis and in Vitro anti-HIV-1 Evaluation of Some N-Arylsulfonyl-3-formylindoles. Che, Z.P., Y. Tian, S.M. Liu, M. Hu, and G.Q. Chen. Brazilian Journal of Pharmaceutical Sciences, 2018. 54(3): e17044. ISI[000452192300001].
[WOS]. HIV_12_2018.
4. Novel Natural Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase Identified by Shape- and Structure-based Virtual Screening Techniques. Costa, G., R. Rocca, A. Corona, N. Grandi, F. Moraca, I. Romeo, C. Talarico, M.G. Gagliardi, F.A. Ambrosio, F. Ortuso, S. Alcaro, S. Distinto, E. Maccioni, E. Tramontano, and A. Artese. European Journal of Medicinal Chemistry, 2019. 161: p. 1-10. PMID[30342421].
[PubMed]. HIV_12_2018.
5. Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors Incorporating Aminothiochromane and Aminotetrahydronaphthalene Carboxamide Derivatives as the P2 Ligands. Ghosh, A.K., R.D. Jadhav, H. Simpson, S. Kovela, H. Osswald, J. Agniswamy, Y.F. Wang, S.I. Hattori, I.T. Weber, and H. Mitsuya. European Journal of Medicinal Chemistry, 2018. 160: p. 171-182. PMID[30340140]. PMCID[PMC6237192].
[PubMed]. HIV_12_2018.
6. Bioengineered Intravaginal Isolate of Lactobacillus plantarum Expresses Algal Lectin Scytovirin Demonstrating anti-HIV-1 Activity. Janahi, E.M.A., S. Haque, N. Akhter, M. Wahid, A. Jawed, R.K. Mandal, M. Lohani, M.Y. Areeshi, S. Almalki, S. Das, and S.A. Dar. Microbial Pathogenesis, 2018. 122: p. 1-6. PMID[29870744].
[PubMed]. HIV_12_2018.
7. HEXIM1-Tat Chimera Inhibits HIV-1 Replication. Kukanja, M.L.P., Z.P. Luo, F. Huang, D.C. Cary, B.M. Peterlin, and K. Fujinaga. Plos Pathogens, 2018. 14(11): e1007402. PMID[30395647]. PMCID[PMC6245832].
[PubMed]. HIV_12_2018.
8. Structure-based Virtual Screening toward the Discovery of Novel Inhibitors for Impeding the Protein-Protein Interaction between HIV-1 Integrase and Human Lens Epithelium-derived Growth Factor (LEDGF/p75). Panwar, U. and S.K. Singh. Journal of Biomolecular Structure & Dynamics, 2018. 36(12): p. 3199-3217. PMID[28948865].
[PubMed]. HIV_12_2018.
9. Design, Synthesis and Evaluation of Some Novel 1-Phenyl-3-(5-phenyl-1H-imidazol-1-yl) Thiourea Derivatives as anti-HIV Agents. Singh, R. and S. Ganguly. Indian Journal of Pharmaceutical Education and Research, 2018. 52(4): p. 655-665. ISI[000450531500014].
[WOS]. HIV_12_2018.
10. Design, Synthesis, and Antiviral Evaluation of Novel Hydrazone-substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent Human Immunodeficiency Virus-1 Inhibitors. Wang, Z., D. Kang, M. Chen, G. Wu, D. Feng, T. Zhao, Z. Zhou, Z. Huo, L. Jing, X. Zuo, D. Daelemans, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. Chemical Biology & Drug Design, 2018. 92(6): p. 2009-2021. PMID[30079476].
[PubMed]. HIV_12_2018.
11. Chidamide, a Histone Deacetylase Inhibitor-based Anticancer Drug, Effectively Reactivates Latent HIV-1 Provirus. Yang, W.Q., Z.W. Sun, C. Hua, Q. Wang, W. Xu, Q.W. Deng, Y.B. Pan, L. Lu, and S.B. Jiang. Microbes and Infection, 2018. 20(9-10): p. 626-634. PMID[29126877].
[PubMed]. HIV_12_2018.
12. Investigation of the Molecular Characteristics of Bisindole Inhibitors as HIV-1 Glycoprotein-41 Fusion Inhibitors. Zhou, G.Y., S.D. Chu, A. Nemati, C.S. Huang, B.A. Snyder, R.G. Ptak, and M. Gochin. European Journal of Medicinal Chemistry, 2019. 161: p. 533-542. PMID[30390441]. PMCID[PMC6264915].
[PubMed]. HIV_12_2018.
Patent Citations
13. Compositions and Methods for Reactivating Latent Immunodeficiency Virus Using a Glycogen Synthase Kinase 3 (GSK-3) Inhibitor. Gramatica, A. and W.C. Greene. Patent. 2018. 2018-US36101 2018226721: 147pp.
[Patent]. HIV_12_2018.